Research and experimental development on natural sciences and engineering
ENZYFERM AS
Revenue 2024
NOK 690,000
Operating profit
NOK −1.3m
Equity
NOK −299,000
Incorporated
2023
Share capital
NOK 1.0m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 690k | |
| Total operating costs | 2.0m | |
| Operating profit (EBIT) | −1.3m | |
| Net financial items | −30k | |
| Profit for the year | −1.3m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 1.6m | |
| of which current assets | 1.6m | |
| Equity | −299k | |
| Total liabilities | 1.9m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.